This chemical is primarily used in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other therapeutic agents targeting specific enzymes. Its structure, featuring a difluorocyclohexyl group and a Boc-protected amino acid, makes it a valuable intermediate in medicinal chemistry. It is often employed in peptide synthesis and drug discovery processes, where it contributes to the creation of molecules with enhanced stability and bioavailability. Additionally, its chiral nature allows for the production of enantiomerically pure compounds, which is crucial for achieving desired biological activity in drug candidates.